Summary
The effect of two anthracyclines-doxorubicin hydrochloride (adriamycin) and 4′-epidoxorubicin (epirubicin) and an anthracenedione (novantrone) on the contractibility and surface ultrastructure of newborn rat cardiomyocytes cultered for five days was examined. While the beating rate of the cells was affected only by the anthracyclines, an alteration of the sarcolemma, disruption of the slender processes and swelling of the nuclei and/or the cells was observed following incubation with each of the three drugs for two hours. However, the damage induced by adriamycin was more pronounced than that induced by the other two drugs, when doses extrapolated from those accepted as therapeutic were compared.
Similar content being viewed by others
References
Arcamone F, Penco S, Vigevani A, Redaelli S, Franchi G, Di Marco A, Casazza AM, Dasdia T, Formelli F, Soranzo C (1975) Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone. J Med Chem 18:703–707
Ashraf M, Onda M, Benedict J, Hirohata Y (1981) Surface ultrastructural features of isolated perfused rat hearts during calcium paradox. Sean Electron Microsc Pt 3:109–114.
Benjamin RS, Chawla SP, Ewer MS, Carrasco CH, Mackay B, Holmes F (1985) Evaluation of mitoxantrone cardiac toxicity by nuclear angiography and endomyocardial biopsy: an update. Invest New Drugs 3:117–121
Billingham ME, Mason JW, Bristow MR, Daniels JR (1978) Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep 62:865–872
Caroni P, Villani F, Carafoli E (1981) The cardiotoxic antibiotic doxorubicin inhibits the Na+/Ca2+ exchange of dog heart sarcolemmal vesicles. Febs Lett 130:184–186
Carter SK (1975) Adriamycin: a review. J Natl Cancer Inst 55:1265–1274
Carter SK, Bakowsky MJ, Hellmann K (1976) Hematologic malignancies. In: Chemotherapy of Cancer. J. Wiley and Sons, New York, p 234
Casazza AM, Di Marco A, Hertazzoli C, Formelli F, Giuliani F, Pratesi G (1980) In: Siegenthaler W, Luthy R (eds) Current Chemotherapy. American Society for Microbiology Washington, p 1257
Claycomb WC, Palazzo MC (1980) Culture of the terminally differentiated adult cardiac muscle cell: A light and scanning electron microscope study. Dev Biol 80:466–482
Coltman C (1983) Phase II study of mitoxantrone HCl using a single dose every 3 weeks. Schedule for adult patients with solid tumours. A multicentre SWOG co-operative trial. Lederle Laboratories. Data on file
Davis HL, Davis TE (1979) Daunorubicin and adriamycin in cancer treatment: an analysis of their roles and limitations. Cancer Treat Rep 63:809–815
De Haan RL, Hirakow R (1972) Synchronization of pulsation rates in isolated cardiac myocytes. Exp Cell Res 70:214–220
Smith IE (1983) Mitoxantrone (novantrone): a review of experimental and early clinical studies. Cancer Treat Rev 10:103–115
Strohm GH II, Payne CM, Alberts DS, Peng YM, Moon TE, Bahl JJ, Bressler R (1982) Cardiotoxic effects of doxorubicin with and without carnitine. Usefulness of the mouse model in assessment. Arch Pathol Lab Med 106:181–185
Stuart-Harris RC, Smith IE (1982) Mitoxantrone: A phase II study in the treatment of patients with advanced breast carcinoma and other solid tumours. Cancer Chemother Pharmacol 8:179–182
Villani F, Favalli L, Piccinini F (1980) Relationship between the effect on calcium turnover and early cardiotoxicity of doxorubicin and 4′-epi-doxorubicin in guinea pig heart muscle. Tumori 66:689–697
White RJ, Durr FE (1985) Development of mitoxantrone. Invest New Drugs 3:85–93
Yoneda S, Toyama S (1978) Scanning electron microscopic studies on cultured heart cells after the induction of arrhythmias and fibrillation. Cardiovasc Res 12:201–211
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Djaldetti, M., Gilgal, R., Shainberg, A. et al. SEM observations on the effect of anthracycline drugs on cultured newborn rat cardiomyocytes. Basic Res Cardiol 83, 672–677 (1988). https://doi.org/10.1007/BF01906962
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01906962